Get started
Author

Ruiling Ning

Clonal Architecture of EGFR Mutation Predicts the Efficacy of EGFR-Tyrosine Kinase Inhibitors in Advanced NSCLC: A Prospective Multicenter Study (NCT03059641)
2020 · Xinghao Ai, Jiuwei Cui, et al. · Clinical Cancer Research · 40
Wogonoside induces apoptosis in human non-small cell lung cancer A549 cells by promoting mitochondria dysfunction
2018 · Min Luo, Juanmei Mo, et al. · Biomedicine & Pharmacotherapy · 25
STRN-ALK Fusion in Lung Adenocarcinoma with Excellent Response Upon Alectinib Treatment: A Case Report and Literature Review
2020 · Cuiyun Su, Ya Jiang, et al. · OncoTargets and Therapy · 24
PDF
Identification of non-invasive biomarkers for predicting the radiosensitivity of nasopharyngeal carcinoma from serum microRNAs
2020 · Kaiguo Li, Xiaodong Zhu, et al. · Scientific Reports · 22
PDF
PD-1/PD-L1 inhibitors plus anti-angiogenic agents with or without chemotherapy versus PD-1/PD-L1 inhibitors plus chemotherapy as second or later-line treatment for patients with advanced non-small cell lung cancer: A real-world retrospective cohort study
2022 · Shubin Chen, Haowen Wei, et al. · Frontiers in Immunology · 10
PDF
Efficacy of bevacizumab versus epidermal growth factor receptor inhibitors for wild-type RAS metastatic colorectal cancer: a meta-analysis
2018 · Wei Jiang, Qitao Yu, et al. · OncoTargets and Therapy · 10
PDF
Clinical characteristics of acquired anti-IFN-γ autoantibodies in patients infected with non-tuberculous mycobacteria: a prospective cohort study
2025 · Hanlin Liang, Siqiao Liang, et al. · BMC Pulmonary Medicine · 9
Prognostic value of the lactate dehydrogenase to albumin ratio in advanced non-small cell lung cancer patients treated with the first-line PD-1 checkpoint inhibitors combined with chemotherapy
2025 · Meifeng Luo, Huiting Wei, et al. · Frontiers in Immunology · 7
PDF
Azithromycin Mitigates Tobacco Smoke-Induced Lung Senescence by Modulating the FOXO3A/CCND1 Signaling Pathway
2025 · Zhangrong Chen, Qiaoli He, et al. · International Journal of COPD · 5
PDF
Integrative habitat analysis and multi-instance deep learning for predictive model of PD-1/PD-L1 immunotherapy efficacy in NSCLC patients: a dual-center retrospective study
2025 · Xiaoxiao Huang, Xiaoxin Huang, et al. · BMC Medical Imaging · 4
PDF
Case Report: The effective treatment of patients in advanced no-small cell lung cancer patients with EGFR G719X/S768I/L861Q and acquired MET amplification: A case series and literature review
2023 · Yun Zhao, Cuiyun Su, et al. · Frontiers in Oncology · 4
PDF
Systemic immune-inflammation index as a prognostic indicator in patients with advanced non–small cell lung cancer receiving first-line chemotherapy combined with immunotherapy
2025 · Meifeng Luo, Shichao Wu, et al. · Oncology and Translational Medicine · 3
Pretreatment plasma d -dimer levels as an independent prognostic factor for overall survival among patients with advanced non-small-cell lung cancer
2020 · Qianfei Liu, Jianbo He, et al. · Journal of International Medical Research · 3
Causal linkage between angiotensin-converting enzyme 2 and risk of lung cancer: a bidirectional two-sample Mendelian randomization study
2024 · Shubin Chen, Ruiling Ning, et al. · Frontiers in Medicine · 2
PDF
NSCLC patients with rare EGFR Ex19del/G724S mutation showed good response to afatinib combined with chemotherapy treatment: A two-case report
2022 · Huilin Wang, Qitao Yu, et al. · Frontiers in Oncology · 2
PDF
STRN-ALK Fusion in Lung Adenocarcinoma with Excellent Response Upon Alectinib Treatment: A Case Report and Literature Review
2020 · Su C, Jiang Y, et al. · DOAJ (DOAJ: Directory of Open Access Journals) · 2
Predictive value of tumor genetic alteration profiling for chemotherapy and EGFR‑TKI treatment in advanced NSCLC
2020 · Wei Jiang, Aiping Zeng, et al. · Oncology Letters · 2
PDF
Prognostic Significance of Pretreatment Plasma D-dimer Levels in EGFR-Positive Advanced Non-Small Cell Lung Cancer Patients Receiving Osimertinib: A Multicentre Retrospective Study
2023 · Qianfei Liu, Liping Tan, et al. · International Journal of General Medicine · 1
PDF
The Effect of PD-1 Inhibitor Combined with Chemotherapy on the Level of Peripheral Blood T Lymphocytes among Patients with Non-Small-Cell Lung Cancer and Its Relationship with Prognosis
2022 · Yun Zhao, Jianbo He, et al. · Computational and Mathematical Methods in Medicine · 1
PDF
Efficacy of bevacizumab versus epidermal growth factor receptor inhibitors for wild-type RAS metastatic colorectal cancer: a meta-analysis
2018 · Jiang W, Yu Q, et al. · DOAJ (DOAJ: Directory of Open Access Journals) · 1
Research progress on lactate metabolism in lung cancer: Tumorigenesis, drug resistance and clinical translation (Review)
2026 · Yuantao Zhang, Yiyang Shang, et al. · Oncology Reports
PDF
Decreased expression levels of Annexin V⁺/CD41⁺ platelet-derived microparticles in peripheral circulation blood and their auxiliary diagnostic value for patients with lung cancer complicated by pulmonary thromboembolism: An exploratory analysis
2026 · Kunpeng Bu, Peigeng He, et al. · Research Square
PDF
Abstract CT299: Dirozalkib versus crizotinib in advanced ALK-positive non-small cell lung cancer (NSCLC): Results from the multicenter, randomized, open-label phase 3 trial
2026 · Ying Liu, Xiangjiao Meng, et al. · Cancer Research
Abstract CT243: Dirozalkib in patients with advanced ALK-positive non-small cell lung cancer (NSCLC): Results from a phase 2 study
2026 · Ying Liu, Yan Yu, et al. · Cancer Research
Specific Efficacy and Safety in the Clinical Application of Anlotinib for Thymic Carcinoma.
2025 · Jianbo He, Qianfei Liu, et al. · PubMed
Works count: 52
Citation count: 177
H-index: 7
I10-index: 6
Year
Topic
Type